<DOC>
	<DOCNO>NCT01979068</DOCNO>
	<brief_summary>- Vascular Inflammation key factor pathogenesis outcome atherosclerosis . 18FDG-PET promising novel tool identify quantify vascular inflammation within atherosclerotic plaque - Recently , unique subset obese individual , metabolically obese normal weight ( MONW ) metabolically healthy obese ( MHO ) , get attention - Therefore , purpose study examine relationship vascular inflammation , measure FDG-PET , various body size phenotype</brief_summary>
	<brief_title>Vascular Inflammation Stratified Body Size Phenotype</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Healthy patient visit routine medical check clinic history CVD ( myocardial infarction , unstable angina , stroke , cardiovascular revascularization ) stage 2 hypertension ( rest blood pressure , â‰¥160/100 mmHg ) history inflammatory condition affect study result take medication might affect inflammatory status , include steroid nonsteroidal antiinflammatory drug within 6 month malignancy severe renal hepatic disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>